Chemogenomic inference of peptide receptor ligands == The GPCRdb similarity search tool was used to identify class A GPCRs with a comparable binding pocket sized using thestructure-basedGPCRdb numbering plan (Isberg etal., 2015). individual GPR139 in a Fluo-4 Ca2+-assay. All three Igf2r peptides, as well as their particular conserved primary motif HFRW, were identified to stimulate GPR139 in the low micromolar range. Moreover, we identified that peptides consisting of nine or Umibecestat (CNP520) tenN-terminal residues of -MSH stimulate GPR139 in the submicromolar range. -MSH1-9was identified to correspond to the product of the predicted cleavage site in the pre-pro-protein pro-opiomelanocortin (POMC). Our results demonstrate that GPR139 is a peptide receptor, activated by ACTH, -MSH, -MSH, the conserved core motif HFRW as well as a potential endogenous peptide -MSH1-9. Further studies are required to determine the functional relevance of GPR139 mediated signaling by these peptides. Keywords: Orphan GPCR, GPR139, Pro-opiomelanocortin (POMC), Adrenocorticotropic hormone (ACTH), Melanocyte revitalizing hormone (MSH), Peptide receptor == Shows == Using GPCRdb we found the binding cavity of GPR139 is 49% similar to MC4R. ACTH, -MSH and -MSH activate GPR139 in the low M-range. We predicted a novel feasible cleavage site in POMC leading to the peptide -MSH1-9. -MSH1-9activates GPR139 in the substantial nM range. == Abbreviations == N-terminal acetylation adrenocorticotropic hormone CHO-k1 cell series stably conveying the human GPR139 receptor CHO-k1 cell series stably Umibecestat (CNP520) conveying Umibecestat (CNP520) the human muscarinic acetylcholine receptor M1 substance 1a (2-(3, 5-dimethoxybenzoyl)-N-(naphthalen-1-yl)hydrazine-1-carboxamide) a GPR139 agonist the focus giving 50% of maximum response G protein-coupled receptor G protein-coupled receptor 139 high performance liquid chromatography liquid chromatography-mass spectrometry matrix-assisted laser beam ionization-time-of-flight mass spectrometry the melanocortin several receptor the melanocortin 4 receptor melanin-concentrating hormone C-terminal amidation net peptide content prohormone convertase 1 enzyme prohormone convertase 2 enzyme phenylalanine pro-opiomelanocortin similarity % thyrotropin liberating hormone tryptophan -melanocyte revitalizing hormone peptide with the series SYSMEHFRWG peptide with the series SYSMEHFRW peptide with the series MEHFRWG peptide with the series MEHFRWGKPV -melanocyte stimulating hormone peptide with all the sequence DEGPYRMEHFRWGFPPKD 1-melanocyte revitalizing hormone == 1 . Launch == G protein-coupled receptors (GPCRs) constitute the largest family of cell surface receptors, encoded by more than 800 genes in humans (Fredriksson ainsi que al., 2003). Given the importance of GPCRs in many aspects of physiology, they may be among the most pursued targets pertaining to drug advancement and they are the cause of approximately 19% of the established drug-targeted part of the genome (Rask-Andersen ainsi que al., 2011). However there is certainly still a huge untapped possibility of drug finding within the GPCR field owing to the fact that these drugs only act on less than a quarter Umibecestat (CNP520) in the 400 non-olfactory GPCRs. Furthermore, 121 non-olfactory GPCRs are still classified since orphan GPCRs, meaning that their particular endogenous ligands, signaling pathways and biological functions have not yet been identified (Southan et al., 2016). The class A GPCR GPR139 is usually an orphan receptor meaning that its endogenous agonist is usually unknown. The expression pattern of GPR139 provides primarily been studied within the mRNA level and demonstrated expression generally in the central nervous system (Liu ainsi que al., 2015, Matsuo ainsi que al., 2005, Ssens ainsi que al., 2006, Wagner ainsi que al., 2016). Attempts to do autoradiography on brain slices from mice with radioligands for GPR139 have failed (Kuhne ainsi que al., 2016, Liu ainsi que al., 2015). While a number of antibodies against GPR139 are commercially available, just one antibody against theN-terminal of GPR139 have already been described in the literature, which locate GPR139 expression to the medial habenula and horizontal septal nucleus (Liu ainsi que al., 2015). Furthermore, GPR139 mRNA have been detected in high levels in the hypothalamus, in the pituitary and in the habenula in the brain (Liu et al., 2015, Matsuo et al., 2005, Wagner et al., 2016). These findings possess led to the hypothesis that GPR139 could be involved in the regulation of food consumption and/or energy costs (Wagner ainsi que al., 2016). Moreover, an Umibecestat (CNP520) additional study indicates that activation of GPR139 with a surrogate agonist (JNJ-63533054) leads to decreased spontaneous locomotion activity in rats (Liu et al., 2015). We have previously demonstrated that bothd- andl-isomers in the.